MRNA
Price
$61.07
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
27 days until earnings call
VIR
Price
$7.59
Change
+$0.26 (+3.55%)
Updated
Oct 4, 10:41 AM (EDT)
27 days until earnings call
Ad is loading...

MRNA vs VIR

Header iconMRNA vs VIR Comparison
Open Charts MRNA vs VIRBanner chart's image
Moderna
Price$61.07
Change-$0.00 (-0.00%)
Volume$4.71M
CapitalizationN/A
Vir Biotechnology
Price$7.59
Change+$0.26 (+3.55%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
MRNA vs VIR Comparison Chart
Loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MRNA vs. VIR commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a StrongBuy and VIR is a Buy.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (MRNA: $61.07 vs. VIR: $7.33)
Brand notoriety: MRNA: Notable vs. VIR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 89% vs. VIR: 85%
Market capitalization -- MRNA: $25.27B vs. VIR: $1.03B
MRNA [@Biotechnology] is valued at $25.27B. VIR’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, VIR is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • MRNA’s TA Score: 3 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VIR is a better buy in the short-term than MRNA.

Price Growth

MRNA (@Biotechnology) experienced а -4.47% price change this week, while VIR (@Biotechnology) price change was +0.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.23%. For the same industry, the average monthly price growth was +2.55%, and the average quarterly price growth was -6.34%.

Reported Earning Dates

MRNA is expected to report earnings on Oct 31, 2024.

VIR is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+3.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($25.3B) has a higher market cap than VIR($1.03B). VIR YTD gains are higher at: -27.137 vs. MRNA (-38.592). VIR has higher annual earnings (EBITDA): -525.76M vs. MRNA (-3.78B). MRNA has more cash in the bank: 8.49B vs. VIR (1.15B). VIR has less debt than MRNA: VIR (115M) vs MRNA (1.27B). MRNA has higher revenues than VIR: MRNA (4.99B) vs VIR (57.6M).
MRNAVIRMRNA / VIR
Capitalization25.3B1.03B2,459%
EBITDA-3.78B-525.76M718%
Gain YTD-38.592-27.137142%
P/E RatioN/AN/A-
Revenue4.99B57.6M8,660%
Total Cash8.49B1.15B737%
Total Debt1.27B115M1,103%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNAVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX1.980.09
+4.76%
Context Therapeutics
PULM2.090.07
+3.47%
Pulmatrix
AMH38.10-0.03
-0.08%
American Homes 4 Rent
ATRO19.32-0.39
-1.98%
Astronics Corp
LRN82.07-1.94
-2.31%
Stride

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with BNTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
-3.31%
BNTX - MRNA
49%
Loosely correlated
+0.67%
RCKT - MRNA
45%
Loosely correlated
-5.31%
RXRX - MRNA
43%
Loosely correlated
-0.82%
VIR - MRNA
42%
Loosely correlated
-4.56%
NTLA - MRNA
42%
Loosely correlated
-4.85%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with TECH. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-4.56%
TECH - VIR
52%
Loosely correlated
-4.43%
ABCL - VIR
49%
Loosely correlated
N/A
NTLA - VIR
49%
Loosely correlated
-4.85%
AVIR - VIR
48%
Loosely correlated
-1.19%
LXRX - VIR
47%
Loosely correlated
N/A
More